Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration

References

• Lee B, Sur B, Yeom M, et al. Alpha-asarone, a major component of Acorus gramineus, attenuates corticosterone-induced anxiety-like behaviours via modulating TrkB signaling process. Korean J Physiol Pharmacol. 2014;18:191–200.
   PubMed Web of Science ®Google Scholar
• Chen Q-X, Miao J-K, Li C, et al. Anticonvulsant activity of acute and chronic treatment with a-asarone from Acorus gramineus in seizure models. Biol Pharm Bull. 2013;36:23–30.
   PubMed Web of Science ®Google Scholar
• Zhao L-H, Wu J-M, Wu F-L. A review of recent ten-year study on alpha-asarone. China J Chinese Materia Medica. 2007;32:562–565.
   Google Scholar
• Liang J, Huang B, Wang G. Chemical composition, antinociceptive and anti-inflammatory properties of essential oil from the roots of Illicium lanceolatum. Nat Product Res. 2012;26:1712–1714.
   PubMed Web of Science ®Google Scholar
• Daniel Limon I, Mendieta L, Diaz A, et al. Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta((25-35)). Neurosci Lett. 2009;453:98–103.
   PubMed Web of Science ®Google Scholar
• Gu Q, Du H, Ma C, et al. Effects of alpha-asarone on the glutamate transporter EAAC1 in Xenopus oocytes. Planta Med. 2010;76:595–598.
   PubMed Web of Science ®Google Scholar
• Huang C, Li W-G, Zhang X-B, et al. Alpha-asarone from Acorus gramineus alleviates epilepsy by modulating A-Type GABA receptors. Neuropharmacology. 2013;65:1–11.
   PubMed Web of Science ®Google Scholar
• Yang Z-H, Wu C. Absolute bioavailability of synthetic asarone in healthy volunteers. Chin J Hosp Pharm. 1997;17:165–167.
   Google Scholar
• Wu C. Study on the bioavailability of asarone tablets. Chin J Hosp Pharm. 2003;10:597–598.
   Google Scholar
• Lu H, Li J-B, Li M, et al. Systemic delivery of alpha-asarone with Kolliphor HS 15 improves its safety and therapeutic effect on asthma. Drug Deliv. 2015;22:266–275.
   PubMed Web of Science ®Google Scholar
• Ren C, Gong T, Sun X, et al. Alpha-asarone incorporated in mixed micelles suitable for intravenous administration: formulation, in-vivo distribution and anaphylaxis study. Pharmazie. 2011;66:875–880.
   PubMed Web of Science ®Google Scholar
• Ma W-C, Zhang Q, Li H, et al. Development of intravenous lipid emulsion of α-asarone with significantly improved safety and enhanced efficacy . Int J Pharm. 2013;450:21–30.
   PubMed Web of Science ®Google Scholar
• Wang DK, Shi ZH, Liu L, et al. Development of self-microemulsifying drug delivery systems for oral bioavailability enhancement of alpha-Asarone in beagle dogs. PDA J Pharm Sci Technol. 2006;60:343–349.
   PubMedGoogle Scholar
• Wang D, Wang X, Li X, et al. Preparation and characterization of solid lipid nanoparticles loaded with alpha-asarone. PDA J Pharm Sci Technol. 2008;62:56–65.
   PubMedGoogle Scholar
• Buyukozturk F, Benneyan JC, Carrier RL. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release. 2010;142:22–30.
   PubMed Web of Science ®Google Scholar
• Sha XY, Yan GJ, Wu YJ, et al. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 2005;24:477–486.
   PubMed Web of Science ®Google Scholar
• Baka E, Comer JEA, Takacs-Novak K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335–341.
   PubMed Web of Science ®Google Scholar
• Ingels F, Beck B, Oth M, et al. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int J Pharm. 2004;274:221–232.
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001;46:27–43.
   PubMed Web of Science ®Google Scholar
• Koljonen M, Hakala KS, Ahtola-Satila T, et al. Evaluation of cocktail approach to standardise Caco-2 permeability experiments. Eur J Pharm Biopharm. 2006;64:379–387.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Ju Y, et al. Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system. Mol Pharm. 2015;12:504–513.
   PubMed Web of Science ®Google Scholar
• Lindmark T, Kimura Y, Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther. 1998;284:362–369.
   PubMed Web of Science ®Google Scholar
• Masungi C, Borremans C, Willems B, et al. Usefulness of a novel caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. J Pharm Sci. 2004;93:2507–2521.
   PubMed Web of Science ®Google Scholar
• Jumarie C, Malo C. Alkaline phosphatase and peptidase activities in Caco-2 cells: differential response to triiodothyronine. In Vitro Cell Dev Biol Anim. 1994;30A:753–760.
   PubMed Web of Science ®Google Scholar
• Zhu M-L, Liang X-L, Zhao L-J, et al. Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model. J Ethnopharmacol. 2013;150:553–559.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today. 2007;12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Joshi HN, Tejwani RW, Davidovich M, et al. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int J Pharm. 2004;269:251–258.
   PubMed Web of Science ®Google Scholar